冠忠巴士集團(00306.HK):與億航智能訂立採購及運營合作協議
格隆匯7月19日丨冠忠巴士集團(00306.HK)宣佈,於2024年7月19日,冠忠智慧出行(為公司的全資附屬公司)與億航智能就產品之合作訂立合作協議,年期由2024年7月19日至2026年12月31日止,據此,(i)於合作協議之年期內,冠忠智慧出行同意採購而億航智能同意銷售30件產品,代價為人民幣6660萬元;(ii)冠忠智慧出行於香港、澳門及湖北省襄陽市之旅遊及出行營運場景中擁有產品的獨家營運權及獨家銷售權;及(iii)冠忠智慧出行於湖北省十堰市之旅遊及出行營運場景中擁有產品的非獨家營運權及非獨家銷售權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.